Optimization of 6,7-disubstituted-4-(arylamino)quinoline-3-carbonitriles as orally active, irreversible inhibitors of human epidermal growth factor receptor-2 kinase activity.

Source:http://linkedlifedata.com/resource/pubmed/id/15715478

J. Med. Chem. 2005 Feb 24 48 4 1107-31

Download in:

View as

General Info

PMID
15715478